Allianz Asset Management’s GSK GSK Stock Holding History

Allianz Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,000	Closed	-$607K	–	2185
2026 Q1	$607K	Buy	+11,000	New	+$596K	﹤0.01%	1818
2022 Q3	–	Sell	-162,676	Closed	-$8.85M	–	1989
2022 Q2	$8.85M	Buy	+162,676	New	+$8.98M	0.01%	932
2020 Q4	–	Sell	-43,816	Closed	-$2.06M	–	1891
2020 Q3	$2.06M	Sell	43,816 -42,991	-50%	-$2.15M	﹤0.01%	1257
2020 Q2	$4.43M	Sell	86,807 -33,129	-28%	-$1.7M	0.01%	1256
2020 Q1	$5.68M	Buy	119,936 +44,879	+60%	+$2.39M	0.01%	1101
2019 Q4	$4.41M	Sell	75,057 -7,448	-9%	-$414K	﹤0.01%	1537
2019 Q3	$4.4M	Sell	82,505 -6,397	-7%	-$329K	﹤0.01%	1506
2019 Q2	$4.45M	Sell	88,902 -11,823	-12%	-$593K	﹤0.01%	1559
2019 Q1	$5.26M	Sell	100,725 -71,518	-42%	-$3.57M	0.01%	1435
2018 Q4	$8.23M	Buy	172,243 +110,651	+180%	+$5.45M	0.01%	1210
2018 Q3	$3.09M	Buy	+61,592	New	+$3.13M	﹤0.01%	1774
2015 Q2	–	Sell	-6,192,094	Closed	-$357M	–	2420
2015 Q1	$357M	Buy	6,192,094 +184,027	+3%	+$10.6M	0.41%	57
2014 Q4	$321M	Sell	6,008,067 -46,340	-0.8%	-$2.59M	0.36%	59
2014 Q3	$348M	Buy	6,054,407 +263,999	+5%	+$16.2M	0.42%	53
2014 Q2	$387M	Buy	+5,790,408	New	+$392M	0.49%	46
2013 Q4	–	Sell	-400,000	Closed	-$25.1M	–	1878
2013 Q3	$25.1M	Hold	400,000	–	–	0.03%	470
2013 Q2	$25M	Buy	+400,000	New	+$25.4M	0.04%	452

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Allianz Asset Management's GSK Position: Q2 2026 in Review

Allianz Asset Management sold out of GSK (GSK) in Q2 2026, closing a stake of 11,000 shares — an estimated $607K sold.

Allianz Asset Management first reported a position in GSK in Q2 2013 and held it in 17 quarters. The position peaked at $387M in Q2 2014. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Allianz Asset Management reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
Allianz Asset Management sold 11,000 GSK shares in Q2 2026, an estimated $607K.
Allianz Asset Management first reported a position in GSK in Q2 2013 and held it in 17 quarters.
Allianz Asset Management's GSK position peaked at $387M in Q2 2014.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.